Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 10 reviews

530%
440%
330%
20%
10%
Ask AI

Ask Trustburn about SciCann

Based on 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About SciCann

SciCann is a Canadian–Israeli pharmaceutical company that develops and commercializes pharmaceutical products that target and modulate the endocannabinoid system that include new therapeutic agents, drug candidates, novel cannabis genetics, and personalized treatment tools. It is active in the fields of oncology, pain management, neurodegenerative diseases, and inflammatory disorders. It develops a line of proprietary products for the treatment of chosen life-threatening conditions that present a high level of unmet need. SciCann holds a diversified portfolio of intellectual property and ownerships in ventures operating in cannabinoid science. It maintains a wide network of strategic and synergistic collaborations with research institutes and commercial companies in the space. It performs its research and development in Israel with commercialization in Canada.